CVS Health Overview
Valuation check: CVS.TO's ROE is 6.16%, above the Healthcare sector average of -75.59%.
Get informed when a big investor buys or sells
+ Follow6.16%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CVS Health (CVS.TO) currently reports a ROE of 6.16%. That is above the Healthcare sector average of -75.59%. Use the charts on this page to explore CVS Health's ROE history and peer comparisons.
CVS Health's ROE of 6.16% is higher than the Healthcare sector average of -75.59%. That is roughly 108.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CVS Health's current 6.16% should be judged against Healthcare norms (sector average: -75.59%) and against CVS.TO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 6.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.59%. From there, open related valuation or income-statement pages for CVS Health, and consider following CVS.TO for alerts when major investors trade the stock.
CVS Health is classified in the Healthcare sector. On ROE, it currently shows 6.16% versus a sector average near -75.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVS.TO with unrelated industries.
